Concepedia

Hongmiao Sheng

HS

50

Publications

7K

Citations

38

H-Index

1992

Active since

Affiliations

Vanderbilt University Medical Center(Current)

The University of Texas Medical Branch at Galveston

Indiana University – Purdue University Indianapolis

Vanderbilt University

Indiana University School of Medicine

Hongmiao Sheng is an author at Vanderbilt University Medical Center specializing in medicine, cell biology, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingPathologyTumor BiologyTumor MicroenvironmentImmunologyCancer ResearchSignal TransductionInflammation

Publications per year

1992–2012

50

Publications

50

Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

Hongmiao Sheng, Jian‐Hua Shao, Jason D. Morrow et al. · PubMed · 1998 · 1.1K citations

Chemoprevention Strategy, Apoptosis, Cell Death +21

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

Hongmiao Sheng, Jian‐Hua Shao, Susan C. Kirkland et al. · Journal of Clinical Investigation · 1997 · 722 citations · Full text

Inflammation, Selective Inhibition, Chemoprevention Strategy +15

Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells

Hongmiao Sheng, Jinyi Shao, M. Kay Washington et al. · Journal of Biological Chemistry · 2001 · 649 citations · Full text

Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.

Christopher S. Williams, Alastair J.M. Watson, Hongmiao Sheng et al. · PubMed · 2000 · 316 citations

Normal Gut, Chemoprevention Strategy, Pathology +17

Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells

Jinyi Shao, Hongmiao Sheng, Hiroyasu Inoue et al. · Journal of Biological Chemistry · 2000 · 261 citations · Full text

Rows per page

1–5 of 50